Biogen Pharma's Q1 FY25 Financial Report Shows Decline in Performance, Receives 'Sell' Rating
Biogen Pharmachem Industries, a microcap trading company, has recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Sell’ call by MarketsMOJO.
According to the financial report, Biogen Pharma’s performance for the quarter has been flat, with a score of -3 compared to 4 in the previous quarter. This indicates a decline in the company’s financial performance in the last three months.
The company’s operating profit (PBDIT) for the quarter was at its lowest in the last five quarters, standing at Rs -0.16 crore. This shows a negative trend in the near term for the company’s operating profit.
Similarly, the profit before tax less other income (PBT) for the quarter was also at its lowest in the last five quarters, at Rs -0.16 crore. This indicates a negative trend in the near term for the company’s PBT.
The earnings per share (EPS) for the quarter was also at its lowest in the last five quarters, at Rs -0.00. This shows a decline in profitability for the company, resulting in lower earnings for shareholders.
Overall, Biogen Pharmachem Industries has reported a negative financial performance for the quarter ending June 2024. Investors should take note of the company’s declining profitability and the ‘Sell’ call given by MarketsMOJO before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
